INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

Currently reading:
INmune Bio stock plunges after clinical hold of IND of Alzheimer's treatment prompts analyst downgrade

T

Tomi Kilgore

MW-GP644_MicroS_ZG_20180906154215.jpg

Shares of INmune Bio Inc. undefined plummeted 31.4% toward a 22-month low in premarket trading Tuesday, after the Florida-based biotechnology company said it...

Continue reading...
 

Similar threads

Wendy’s shares rallied after hours Tuesday as Nelson Peltz’s hedge fund Trian Partners’ disclosed a huge stake in the company and plans for a possible sale. Continue reading...
Replies
0
Views
44
Wallace Witkowski
W
The ride-hailing company’s stock is on pace for its worst month on record and has decreased about 61% so far this year. Continue reading...
Replies
0
Views
34
Levi Sumagaysay
L
Lyft Inc. will slow hiring, reduce the budgets of some of its departments and grant new stock options to some employees to make up for its eroding share... Continue reading...
Replies
0
Views
27
MarketWatch
M
The tax and accounting software company's strong results come economic pressures that are weighing on the company’s many small business customers. Continue reading...
Replies
0
Views
36
Eric J. Savitz
E
Shares of Microsoft Corp. sank 0.40% to $259.62 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones... Continue reading...
Replies
0
Views
29
MarketWatch Automation
M

Users who are viewing this thread

Metaverse listing

Top